Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001209191-21-055725

Director sold 26,468 shares at an average $29.23 ($773,720)

From the SEC's structured data for this filing

Trades in this filing

GADICKE ANSBERT · Director

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-09 Sale : show line 1 in the form −1,898 $29.35 $55,706 248,170 D
2021-09-09 Sale : show line 2 in the form −13,727 $29.35 $402,887 7,674,449 I
2021-09-10 Sale : show line 3 in the form −820 $29.04 $23,813 247,350 D
2021-09-10 Sale : show line 4 in the form −5,931 $29.04 $172,236 7,668,518 I
2021-09-13 Sale : show line 5 in the form −497 $29.10 $14,463 246,853 D
2021-09-13 Sale : show line 6 in the form −3,595 $29.10 $104,615 7,664,923 I
Open-market sales · 26,468 sh · avg $29.23 · $773,720
Loading xslF345X03/doc4.xml…